A someone new to this stock could somebody help me understand why the market cap for this company is so low. It seems like it has so much going for it with marketable drugs and a phase 2 drug with huge potential. Most companies would be valued at 10x-20x so what's wrong with this stock. Thanks
The marketable drugs are newly developed product lines as of a partnership earlier this last year. They've been in development of some blockbuster drugs for several years which are just starting to gain some serious interest. They do have a history of reverse splits and dilution. However internally the managment team has recently hired some significant players in the industry. Insiders are buying shares and approvals are on the horizon. It won't be long before it's value is 10x-20x.